BACKGROUND: Rho kinase signaling plays an important role in the oncogenic process largely through its regulation of F-actin dynamics, and inhibition of this pathway results in reduction in tumor volume and metastasis across a number of tumor types. While the cytoskeletal-regulatory role of Rho kinase has been a topic of in-depth study, the mechanisms linking Rho kinase to altered gene expression are largely unknown. MATERIALS AND METHODS: Global gene expression analysis was performed on melanoma tumors treated with sham or the small molecule inhibitor Y27632. RESULTS: Inhibition of Rho kinase activity in melanoma tumors results in a statistically significant change in gene transcription of 94 genes, many of which are critically involved in tumor initiation and progression. CONCLUSION: In addition to regulating tumorigenesis through modulation of the phosphoproteome, Rho kinase signaling also contributes to the regulation of the tumor transcriptome.
BACKGROUND:Rho kinase signaling plays an important role in the oncogenic process largely through its regulation of F-actin dynamics, and inhibition of this pathway results in reduction in tumor volume and metastasis across a number of tumor types. While the cytoskeletal-regulatory role of Rho kinase has been a topic of in-depth study, the mechanisms linking Rho kinase to altered gene expression are largely unknown. MATERIALS AND METHODS: Global gene expression analysis was performed on melanoma tumors treated with sham or the small molecule inhibitor Y27632. RESULTS: Inhibition of Rho kinase activity in melanoma tumors results in a statistically significant change in gene transcription of 94 genes, many of which are critically involved in tumor initiation and progression. CONCLUSION: In addition to regulating tumorigenesis through modulation of the phosphoproteome, Rho kinase signaling also contributes to the regulation of the tumor transcriptome.
Authors: Catharine A Street; Alissa A Routhier; Carrie Spencer; Ashley L Perkins; Katherine Masterjohn; Alexander Hackathorn; John Montalvo; Emily A Dennstedt; Brad A Bryan Journal: Int J Oncol Date: 2010-11 Impact factor: 5.650
Authors: Brad A Bryan; Emily Dennstedt; Dianne C Mitchell; Tony E Walshe; Kensuke Noma; Robyn Loureiro; Magali Saint-Geniez; Jean-Paul Campaigniac; James K Liao; Patricia A D'Amore Journal: FASEB J Date: 2010-04-16 Impact factor: 5.191
Authors: Pekka T Heikkinen; Marika Nummela; Terhi Jokilehto; Reidar Grenman; Veli-Matti Kähäri; Panu M Jaakkola Journal: Cancer Res Date: 2010-06-15 Impact factor: 12.701
Authors: Christina Hackl; Sven A Lang; Christian Moser; Akira Mori; Stefan Fichtner-Feigl; Claus Hellerbrand; Wolfgang Dietmeier; Hans J Schlitt; Edward K Geissler; Oliver Stoeltzing Journal: BMC Cancer Date: 2010-12-03 Impact factor: 4.430
Authors: Abdessamad Amine; Sofia Rivera; Paule Opolon; Mehdi Dekkal; Denis S F Biard; Hakim Bouamar; Fawzia Louache; Michael J McKay; Jean Bourhis; Eric Deutsch; Marie-Catherine Vozenin-Brotons Journal: PLoS One Date: 2009-03-26 Impact factor: 3.240
Authors: J Montalvo; C Spencer; A Hackathorn; K Masterjohn; A Perkins; C Doty; A Arumugam; P P Ongusaha; R Lakshmanaswamy; J K Liao; D C Mitchell; B A Bryan Journal: Curr Mol Med Date: 2013-01 Impact factor: 2.222